Jazz Pharmaceuticals and RYTHM are competing in the pharmaceutical market and listed on the Nasdaq stock exchange.
4 reports, 1 independent
Updated Fri 00:00
Mostly repetition
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jazz Pharmaceuticals and RYTHM are competing in the pharmaceutical market and listed on the Nasdaq stock exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
-
Nasdaq
American fully electronic stock exchange
Related events
- Argenex SE and Capricor Therapeutics were listed on the Nasdaq stock exchange and are competing in the biotech sector.
- Field Trip Health and Henry Schein are competing in the healthcare technology market and listed on the Nasdaq stock exchange.
- Xenetic Biosciences and XTL Biopharmaceuticals are competing in the small-cap biopharmaceutical space, listed on the Nasdaq stock exchange.
- Cue Biopharma and Nurix Therapeutics are being compared based on financial metrics, with both companies listed on the Nasdaq stock exchange.
- Korro Bio, Inc. and Wellgistics Health were listed on the Nasdaq stock exchange on July 1, 2026.